Repros Therapeutics Inc (NASDAQ:RPRX)

8.43
Delayed Data
As of Apr 24
 -0.06 / -0.71%
Today’s Change
5.92
Today|||52-Week Range
22.55
-15.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$204.6M

Company Description

Repros Therapeutics, Inc. operates as a biopharmaceutical company, which focuses on the development of new drugs to treat hormonal and reproductive system disorders. The company's current product pipeline consists of Androxal, Proellex, Vasomax and Z-Max. Repros Therapeutics was founded on August 20, 1987 and is headquartered in Woodlands, TX.

Contact Information

Repros Therapeutics, Inc.
2408 Timberloch Place
Woodlands Texas 77380
P:(281) 719-3400
Investor Relations:

Employees

Shareholders

Individual stakeholders9.21%
Other institutional42.37%
Mutual fund holders25.93%

Top Executives

Joseph S. PodolskiPresident, Chief Executive Officer & Director
Katherine A. AndersonSecretary, Chief Financial & Accounting Officer
Ronald D. WiehleVice President-Research & Development
Jaye L. ThompsonSenior Vice President-Clinical & Regulatory
Joachim F. WernickeChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account